Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows – News-Medical.net
|
Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows
News-Medical.net The new immunotherapy treatments aim to block the activity of certain proteins that inhibit the immune system. In lung cancer, this therapeutic option has yielded hopeful results in about twenty percent of patients. However, the treatment can only be … |
